With only five patients treated, the role of PD-1/PD-L1 inhibitors given after transplantation for NK/ T-cell lymphoma remains unclear, although unusually early and severe GVHD was not observed. This evidence concerns the gene CD274 and T-cell non-Hodgkin lymphoma.